skip to main content

H.R. 1348 (115th): Investing in Testing Act of 2017

The text of the bill below is as of Mar 2, 2017 (Introduced).


I

115th CONGRESS

1st Session

H. R. 1348

IN THE HOUSE OF REPRESENTATIVES

March 2, 2017

introduced the following bill; which was referred to the Committee on Energy and Commerce

A BILL

To require the Director of the Centers for Disease Control and Prevention to complete a study on the human health implications of per- and polyfluoroalkyl substances (PFAS) contamination in drinking water.

1.

Short title

This Act may be cited as the Investing in Testing Act of 2017.

2.

Study by CDC on health implications of per- and polyfluoroalkyl substances contamination in drinking water

(a)

In general

The Director of the Centers for Disease Control and Prevention shall—

(1)

not later than 60 days after the date of enactment of this Act, commence a study on the human health implications of per- and polyfluoroalkyl substances (PFAS) contamination in drinking water; and

(2)

not later than 2 years and 60 days after the date of enactment of this Act—

(A)

complete such study; and

(B)

submit a report to the Congress on the results of such study.

(b)

Authorization of appropriations

To carry out this Act, there is authorized to be appropriated $15,000,000.